| Name |
|---|
BML-286 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-286 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-277 Gene SetFrom DeepCoverMOA Drug Mechanisms of Action proteins with high or low expression in BML-277 relative to other proteins from the DeepCoverMOA Drug Mechanisms of Action dataset. |
BML-284 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-284 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-210 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-210 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-266 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-266 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-278 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-278 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-259 Gene SetFrom LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BML-259 small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset. |
BML-281 Gene Setinteracting proteins for the BML-281 drug from theDGIdb Drug Targets 2026 dataset. |